UniCredit Aktienanleihe MRK 22.11.../ DE000HC6UGB8 /
2024-05-23 2:08:50 PM | Chg.+0.170 | Bid2:33:27 PM | Ask2:33:27 PM | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
101.420EUR | +0.17% | 101.420 Bid Size: 350,000 |
101.500 Ask Size: 350,000 |
MERCK KGAA O.N. | 140.00 - | 2024-11-22 | Call |
GlobeNewswire
1:00 PM
atai Life Sciences Strengthens Board with Appointment of Two New Independent Directors
GlobeNewswire
1:00 PM
Amphista Therapeutics unveils new differentiated mechanism of action for BRD9 degradation at 2024 Pr...
GlobeNewswire
05-07
CytomX Therapeutics Announces Clinical Collaboration with Merck to Evaluate CX-801 in Combination wi...
GlobeNewswire
05-06
Press Release Biocartis NV: Biocartis and Merck to Collaborate on Improving Patient Access to Person...
GlobeNewswire
03-04
C4 Therapeutics Announces Strategic Discovery Research Collaboration with Merck KGaA, Darmstadt, Ger...
GlobeNewswire
2023-12-21
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac ...
GlobeNewswire
2023-12-14
ITM Executes License Agreement to Obtain Worldwide Exclusive License for the Clinical Development an...
GlobeNewswire
2023-10-17
ImmunOs Therapeutics Announces Clinical Trial Collaboration with Merck & Co., Inc., Rahway, NJ, USA